Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Disc Medicine (IRON)
NASDAQ:IRON
Holding IRON?
Track your performance easily
IRON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.60 - $77.60
Previous Close$63.51
Volume282.40K
Average Volume (3M)289.63K
Market Cap
$1.89B
Enterprise Value$1.40B
Total Cash (Recent Filing)$487.36M
Total Debt (Recent Filing)$1.79M
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Mar 28, 2025EPS Estimate
-$1.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.97
Shares Outstanding29,757,732
10 Day Avg. Volume322,679
30 Day Avg. Volume289,633
Standard Deviation0.21
R-Squared0.02
Alpha-0.00838
Financial Highlights & Ratios
Price to Book (P/B)3.98
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-25.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-12.85
Forecast
1Y Price Target
$92.40Price Target Upside42.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Disc Medicine News
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentThe FDA agreed that PPIX reduction may serve as a surrogate endpoint to support the accelerated approval of bitopertin.
Financial PerformanceDisc Medicine finished the period with $487.4M in cash and cash equivalents, which is expected to fund operations well into 2027.
Investor ConfidenceDisc's execution on a turnaround for Bitopertin has reignited investor interest with a viable path to accelerated approval.
Bears Say
Clinical Trial ResultsThe Phase 2 AURORA study did not show significant improvements in light tolerance due to a greater-than-expected placebo response.
Investor SentimentShort interest is relatively high at 9.5% of the float, indicating some investor skepticism.
Risk AssessmentRisks include mixed or negative clinical data, safety concerns for clinical programs, and financing issues.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IRON FAQ
What was Disc Medicine’s price range in the past 12 months?
Disc Medicine lowest stock price was $25.60 and its highest was $77.60 in the past 12 months.
What is Disc Medicine’s market cap?
Currently, no data Available
When is Disc Medicine’s upcoming earnings report date?
Disc Medicine’s upcoming earnings report date is Mar 28, 2025 which is in 125 days.
How were Disc Medicine’s earnings last quarter?
Disc Medicine released its earnings results on Nov 12, 2024. The company reported -$0.89 earnings per share for the quarter, beating the consensus estimate of -$1.037 by $0.147.
Is Disc Medicine overvalued?
According to Wall Street analysts Disc Medicine’s price is currently Undervalued.
Does Disc Medicine pay dividends?
Disc Medicine does not currently pay dividends.
What is Disc Medicine’s EPS estimate?
Disc Medicine’s EPS estimate is -$1.21.
How many shares outstanding does Disc Medicine have?
Disc Medicine has 29,757,732 shares outstanding.
What happened to Disc Medicine’s price movement after its last earnings report?
Disc Medicine reported an EPS of -$0.89 in its last earnings report, beating expectations of -$1.037. Following the earnings report the stock price went down -4.972%.
Which hedge fund is a major shareholder of Disc Medicine?
Among the largest hedge funds holding Disc Medicine’s share is Deerfield Management Company, LP. It holds Disc Medicine’s shares valued at 50M.
---
Disc Medicine Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$92.40 (42.24% Upside)
$92.40 (42.24% Upside)
Blogger Sentiment
Bullish
IRON Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 60.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 42.7%
Last 30 Days ▲ 42.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.71%
12-Months-Change
Fundamentals
Return on Equity
-25.03%
Trailing 12-Months
Asset Growth
31.51%
Trailing 12-Months
Company Description
Disc Medicine
FS Development Corp is a blank check company.
---
IRON Stock 12 Month Forecast
Average Price Target
$92.40
▲(42.24% Upside)
Technical Analysis
Best Analysts Covering IRON
1 Year
1 Year Success Rate
12/13 ratings generated profit
1 Year Average Return
+28.99%
reiterated a buy rating 10 days ago
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +28.99% per trade.
---